Antituberculous drug drug-resistance gene and screening method thereof
A technology for drug resistance genes and anti-tuberculosis drugs, applied in the field of genetic engineering, can solve the problems of complicated operation, high verification difficulty and high cost, and achieve the effects of simple operation, convenient use and promotion of development.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0051] In order to make the object, technical solution and advantages of the present invention more clear, the present invention will be further described in detail below in conjunction with the examples. It should be understood that the specific embodiments described here are only used to explain the present invention, not to limit the present invention.
[0052] The application principle of the present invention will be described in detail below in conjunction with the accompanying drawings.
[0053] The anti-tuberculosis drug resistance genes of the embodiments of the present invention are: pks12, pks5, PPE34, Rv1978, Rv1847, hemK, PPE3, glyA1, PE_PGRS27, PE_PGRS19, Rv1520, Rv1505c, Rv2407, mmuM, vapB17, Rv3727, Rv3737;
[0054] The pks12 gene sequence is SEQ ID NO: 1; the pks5 gene sequence is SEQ ID NO: 2; the PPE34 gene sequence is SEQ ID NO: 3; the Rv1978 gene sequence is SEQ ID NO: 4; the Rv1847 gene sequence is SEQ ID NO: 5; The hemK gene sequence is SEQ ID NO: 6; th...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com